Latest News

  • February 16, 2012

  • Horizon Discovery Joins 4D Cell Fate Consortium

  • Contributes rAAV-mediated genome editing technology to EU FP7 funded project aimed at understanding hES cell differentiation control

  • Read Story

  • January 31, 2012

  • Horizon and UK NEQAS ICC Announce Partnership to Improve Accuracy of Lung Cancer Diagnostic Testing

  • Horizon’s genetically defined human genomic reference standards to be used in FISH and IHC proficiency testing to help guide personalised medicine

  • Read Story

  • January 23, 2012

  • Horizon Discovery Appoints Eric Rhodes as Chief Technical Officer

  • Horizon Discovery has announced the appointment of Eric Rhodes as Chief Technical Officer, Gene Targeting.

  • Read Story

  • January 10, 2012

  • Horizon Discovery announces board member Simon Cook

  • Horizon Discovery, a leading provider of research tools to support the development of personalized medicines, has announced the appointment of Simon Cook as a non-executive director.

  • Read Story

  • November 21, 2011

  • Collaboration with the National Cancer Institute and the National Human Genome Research Institute

  • Horizon’s rAAV gene targeting to be applied in cancer research programs, enabling the NCI and NHGRI to engineer human isogenic disease models.

  • Read Story